2011 SUBMISSION INFORMATION

The Foundation, on behalf of members and the greater community, put together a comprehensive submission to the PBAC demonstrating quality of life benefits for adults who receive growth hormone replacement. 

 

The APF and its members were deeply involved in supporting the application, and are extremely disappointed that once again the application was not successful.  

You will find the results on the Dept of Health & Ageing website
http://www.pbs.gov.au/info/industry/listing/elements/pbac-meetings/pbac-outcomes/2011-07/1st-time-decisions      

(look at column "Drug Use and Type")

We have prepared a summary of the results in lay-man terms - please click here

Thank you to the many people who participated in our survey and who also wrote their personal testimonials to the PBAC. No doubt they had a lot of reading to do!

 

LEARN MORE ABOUT THE 2011
GROWTH HORMONE REPLACEMENT
FOR ADULTS SUBMISSION


The use of Growth Hormone in pituitary deficient patients is NOT about bodybuilding; it is about basic quality of life. Without it, patients can experience:

  • Fatigue and lack of vitality
  • Malaise 
  • Decreased muscle mass 
  • Centralised Obesity
  • High blood fats
  • Reduced bone density
  • Impaired concentration
  • Cardiac anomalies

Patients can generally function, but with little enthusiasm or stamina. Everyday tasks are that much more difficult for a growth hormone deficient patient to achieve.

Growth Hormone is an integral part of standard replacement therapy for patients with established pituitary disease; its benefits have been well studied and its guidelines for use published by various Endocrine Societies worldwide.

A drug that is so critical to the ability of a patient to manage their physical and mental well being should not cost those patients approximately $20 per day*1

There are an estimated 3500*2 adult growth hormone deficient patients in Australia right now.



READ ELIZABETH'S STORY


References
1 Based on a survey of APF members in 2013

2 There are no estimates available in Australia, however based on an estimated prevalence in the UK of 0.02%(Reference: Society for Endocrinology. Topical briefings: adult growth hormone replacement. Bristol, UK: Society for Endocrinology; 2001) and based on the projected number of adults (18+) in 2014 (19,090,700) there are approximately 3,818 adult patients with growth hormone deficiency in Australia.